Monthly Archives: February, 2024

Browse our exclusive articles!

Meta’s Manipulated Media Policy Criticized as Confusing by Oversight Board

Meta's manipulated media policy criticized for confusion by oversight board. Calls for revised policy to address online disinformation targeting elections. Review reveals gaps in policy, particularly regarding altered video of President Biden. Meta urged to cover all types of manipulated media and label rather than remove. Tech companies face scrutiny on handling election falsehoods. Meta reviewing guidance and will respond publicly. Ensuring political speech remains protected while closing policy gaps urged. Meta's 20th anniversary highlights potential for deceptive media on owned platforms. Oversight board recommends updated policy to label manipulated videos. Enforcing policy changes crucial for eroding trust. Consistent and effective strategies needed to combat disinformation.

Ancient Scroll Revealed: AI Unlocks Secrets Buried in Pompeii’s Mount Vesuvius Eruption

Unlocking the secrets of a 2,000-year-old Roman scroll using AI: researchers make groundbreaking discovery on Mount Vesuvius eruption.

Cisco Launches Motific: Expediting GenAI Deployment While Managing Risks

Cisco introduces Motific: Streamlining GenAI deployment & risk management

Bitbot: The World’s First Non-Custodial Telegram Trading Bot Poised to Generate 100x Returns by 2025

Bitbot: The world's first non-custodial Telegram trading bot expected to generate massive 100x returns by 2025. Invest in Bitbot today!

OpenAI CEO Sam Altman Declares ChatGPT-4’s End to Laziness, Promises Impressive Enhancements

OpenAI CEO Sam Altman announces ChatGPT-4's end to laziness, promising impressive enhancements. Get ready for a more agile and efficient AI system!

Popular

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.

Pioneering Research Uncovers Vital Biomarker for Orbital Inflammation

An in-depth study reveals HLF as a potential biomarker for orbital inflammation, offering new insights for diagnosis and treatment strategies.

Subscribe

spot_imgspot_img